Overview
Discusses the use of probiotics in type 1 and 2 diabetes, obesity, metabolic endotoxemia, and liver disorders
Explains mechanism of action and growing status of probiotics as therapeutic strategies in metabolic disorders
Describes animal models for pre-clinical studies in metabolic disorders
Buy print copy
About this book
The volume is a comprehensive compilation describing the scope and application of probiotic and prebiotic therapy in treating metabolic disorders. Readers will discover how probiotics are not just confined to the microbiology industry but are showing promising results in the medical and pharmaceutical sectors.
Similar content being viewed by others
Keywords
Table of contents (13 chapters)
Editors and Affiliations
About the editors
Prof. Kanwaljit Chopra, the former Chairperson of the University Institute of Pharmaceutical Sciences, has prolific experience of 28 years in research and holds distinguished expertise in Neuropharmacology, Diabetes & Metabolic Diseases, Pain, Inflammation, and Menopausal complications. She has more than 215 international and national publications in high-impact journals, acclaimed globally for her research work. She has received eleven prestigious national and international awards. She has fetched grants of over 1.5 Crores from the Government as well as Industry. She has been an active member of National and International societies. Her “Reverse Pharmacology” approach has provided strong leads to the scientific community for the translational potential of various moieties of natural origin.
Dr. Mahendra Bishnoi is working as Scientist E, Food and Nutritional Biotechnology, National Agri-Food Biotechnology Institute, Mohali. He is presently leading a group of young researchers dedicated to metabolic disorders (obesity and type-2 diabetes) research with a particular focus on nutrition and diet, the development of molecular evidence-based functional foods, and nutraceuticals. His scientific work is well recognized in more than 120 peer-reviewed and high-impact factor scientific journals, with around 4000 citations. Dr. Bishnoi is an Alexander von Humboldt Experienced Fellow, Early and Mid-Career Research (EMCR) fellow of Indian National Science Academy (INSA), Melvin Yahr awardee from World Federation of Neurosciences.
Dr. Kondepudi is presently working as Scientist-E in the Food & Nutrition Biotechnology Division at National Agri-Food Biotechnology Institute, an autonomous institute under the Department of Biotechnology, Government of India. Dr. Kondepudi is actively working on developing dietary interventions that could beneficially modulate the gut bacteria and could protect from proinflammatory stress underlying many diseases with an overall goal to develop functional foods based on millets and their bioactive ingredients, dietary fibers, prebiotics, probiotics, and other functional ingredients from different plant sources. His group uses rodent models, nutrigenomic and metagenomic approaches for evaluating the efficacy of bioactive ingredients and functional foods.
Bibliographic Information
Book Title: Probiotic Research in Therapeutics
Book Subtitle: Volume 5: Metabolic Diseases and Gut Bacteria
Editors: Indu Pal Kaur, Kanwaljit Chopra, Mahendra Bishnoi, Kanthi Kiran Kondepudi
DOI: https://doi.org/10.1007/978-981-16-8444-9
Publisher: Springer Singapore
eBook Packages: Chemistry and Materials Science, Chemistry and Material Science (R0)
Copyright Information: Springer Nature Singapore Pte Ltd. 2022
Hardcover ISBN: 978-981-16-8443-2Published: 05 May 2022
Softcover ISBN: 978-981-16-8446-3Published: 06 May 2023
eBook ISBN: 978-981-16-8444-9Published: 04 May 2022
Edition Number: 1
Number of Pages: XIV, 275
Number of Illustrations: 1 b/w illustrations
Topics: Pharmaceutical Sciences/Technology, Pharmacotherapy, Vaccine, Pharmacy, Analytical Chemistry